According to the health ministry, 9,946,867 people have recovered so far with 19,557 patients of Covid-19 cured or discharged across the country in the last 24 hours.
Updated: Jan 04, 2021, 10:23 IST
A health worker collects a swab sample from a woman for coronavirus testing in Noida, India on Saturday. (Sunil Ghosh /HT Photo)
India logged 16,504 cases of the coronavirus disease (Covid-19) and 214 related deaths between Sunday and Monday morning, according to the Union ministry of health and family welfare, which have taken the country’s tally to 10,340,469. There were 16,432 cases of the coronavirus disease on December 29 last year. The number of active cases of Covid-19 remained below the 250,000 mark for the second day on a row at 243,953.
According to the health ministry, 9,946,867 people have recovered so far with 19,557 patients of Covid-19 cured or discharged across the country in the last 24 hours. The national recovery rate has gone up to 96.19%. The daily new recoveries have been more than the daily cases registered since the last 38 days, the health ministry’s data shows. The gap between recovered and active cases has widened further and now stands at 9,702,914.
Drugs Controller General of India (DCGI) VG Somani on Sunday approved Oxford’s Covid-19 vaccine, Covishield, and Bharat Biotech International Limited’s Covaxin for restricted emergency use, clearing way for the government’s vaccination drive against the coronavirus disease in about 10 days. However, the emergency use approval to the Serum Institute of India (SII) vaccine against Covid-19 developed by AstraZeneca and Oxford University, and the “restricted use in emergency situation” consent to Bharat Biotech’s locally developed vaccine has triggered a debate among experts.